PUBLISHER: The Business Research Company | PRODUCT CODE: 1855904
PUBLISHER: The Business Research Company | PRODUCT CODE: 1855904
Immunogenomics Global Market Report 2025
Immunogenomics is a branch of genomics that examines how an individual's genetic makeup influences the immune system's function. It focuses on identifying genetic variations that impact immune responses, susceptibility to infections and autoimmune diseases, and the effectiveness of immunotherapies and vaccines.
The primary product types of immunogenomics include instruments, consumables, software, and services. Instruments are laboratory devices used to analyze genetic material and study the immune system, including sequencers, microarray scanners, and cell sorters. Technologies employed include next-generation sequencing, microarray, polymerase chain reaction, and others. Applications span oncology, infectious diseases, autoimmune disorders, transplantation, and more, serving hospitals and clinics, research institutes, pharmaceutical and biotechnology companies, and other end users.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The immunogenomics market research report is one of a series of new reports from The Business Research Company that provides immunogenomics market statistics, including immunogenomics industry global market size, regional shares, competitors with an immunogenomics market share, detailed immunogenomics market segments, market trends and opportunities, and any further data you may need to thrive in the immunogenomics industry. This immunogenomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The immunogenomics market size has grown rapidly in recent years. It will grow from $5.24 billion in 2024 to $6.09 billion in 2025 at a compound annual growth rate (CAGR) of 16.3%. The growth in the historic period can be linked to rising prevalence of autoimmune diseases, increasing demand for personalized medicine, greater awareness of immunogenomic testing, government funding for healthcare research, and expansion of the biotechnology and pharmaceutical sectors.
The immunogenomics market size is expected to see rapid growth in the next few years. It will grow to $11.00 billion in 2029 at a compound annual growth rate (CAGR) of 15.9%. The growth in the forecast period can be linked to wider adoption of immunogenomic-based therapies, expansion of precision medicine initiatives, increased investment in research and development, growth of healthcare infrastructure, and rising demand for diagnostic solutions. Key trends during the forecast period include advancements in sequencing and genotyping technologies, innovations in immunogenomic assays, progress in bioinformatics and data analysis, development of targeted therapies, and integration of artificial intelligence in immunogenomics.
The rising prevalence of infectious diseases is expected to drive the growth of the immunogenomics market in the near future. Infectious diseases are illnesses caused by harmful microorganisms, including bacteria, viruses, fungi, or parasites, that can spread directly or indirectly from one person to another. The increasing frequency of these diseases is largely attributed to greater global travel, which facilitates the rapid transmission of pathogens across borders. Immunogenomics aids in managing infectious diseases by providing a precise analysis of host immune responses and genetic susceptibility. This approach reduces the trial-and-error nature of treatments by identifying patient-specific immune factors, which helps improve diagnostics, vaccine development, and personalized therapeutic strategies. For example, in February 2024, the UK Health Security Agency reported a 10.7% increase in tuberculosis cases in England, with 4,850 cases in 2023 compared to 4,380 in 2022. Consequently, the growing prevalence of infectious diseases is fueling the growth of the immunogenomics market.
Leading companies in the immunogenomics market are focusing on developing advanced technologies, such as single-cell transcriptome solutions, to provide high-resolution analysis of immune cell diversity and enhance the understanding of complex immune responses. Single-cell transcriptome solutions analyze the complete set of RNA transcripts in individual cells, offering insights into gene expression patterns and cellular heterogeneity within complex tissues. For example, in October 2022, Pacific Biosciences of California Inc. partnered with the Broad Institute of MIT and Harvard, along with 10x Genomics Inc., to launch a Multiplexed Arrays Sequencing (MAS-Seq) kit. This high-throughput, cost-effective sequencing solution enables the full-length analysis of single-cell RNA transcripts, uncovering novel RNA isoforms and mutations with exceptional accuracy. The technology increases sequencing throughput by 16 times by concatenating cDNA molecules and integrates seamlessly with 10x Genomics' single-cell technology and PacBio sequencers. This solution allows researchers to explore cellular heterogeneity at the isoform level, advancing disease research and biomarker discovery.
In January 2025, Adaptive Biotechnologies Corp., a US-based biotechnology firm, partnered with NeoGenomics Laboratories Inc. to enhance advanced immunogenomic testing services. This collaboration aims to expand access to personalized minimal residual disease (MRD) monitoring for blood cancer patients, facilitating tailored treatment strategies and improving patient care through the integration of cutting-edge sequencing and diagnostic technologies. NeoGenomics Laboratories Inc. is a US-based company that specializes in immunogenomics testing services.
Major players in the immunogenomics market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Illumina Inc., BGI Group, GenScript Biotech Corporation, CareDx Inc., Oxford Nanopore Technologies plc, Genewiz LLC, Adaptive Biotechnologies Corporation, GenomOncology LLC, Personalis Inc., Variantyx Inc., CD Genomics Inc., Sengenics Corporation, GeneCentric Therapeutics Inc., Immunogenomics Inc., ImmuQuad Biotechnologies Inc., Neomics Pharmaceuticals LLC, Yemaachi Biotech Ltd., and BioAnalytica Biotechnology Systems Inc.
North America was the largest region in the immunogenomics market in 2024. The regions covered in immunogenomics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the immunogenomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The immunogenomics market also consists of revenues earned by entities by providing services such as immune profiling, bioinformatics analysis, biomarker discovery, and immunotherapy support. The market value includes the value of related goods sold by the service provider or included within the service offering. The immunogenomics market also includes sales of sequencing kits, reagents, microarrays, and bioinformatics tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Immunogenomics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on immunogenomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for immunogenomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The immunogenomics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Product Type: Instruments; Consumables; Software; Services
- 2) By Technology: Next-Generation Sequencing; Microarray; Polymerase Chain Reaction; Other Technologies
- 3) By Application: Oncology; Infectious Diseases; Autoimmune Disorders; Transplantation; Other Applications
- 4) By End-User: Hospitals And Clinics; Research Institutes; Pharmaceutical And Biotechnology Companies; Other End-Users
- Subsegments:
- 1) By Instruments: Sequencers; Microarray scanners; Flow cytometers
- 2) By Consumables: Reagents; Kits; Assay panels
- 3) By Software: Data analysis software; Bioinformatics tools; Visualization platforms
- 4) By Services: Sequencing services; Genomic profiling; Bioinformatics support
- Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Illumina Inc.; BGI Group; GenScript Biotech Corporation; CareDx Inc.; Oxford Nanopore Technologies plc; Genewiz LLC; Adaptive Biotechnologies Corporation; GenomOncology LLC; Personalis Inc.; Variantyx Inc.; CD Genomics Inc.; Sengenics Corporation; GeneCentric Therapeutics Inc.; Immunogenomics Inc.; ImmuQuad Biotechnologies Inc.; Neomics Pharmaceuticals LLC; Yemaachi Biotech Ltd.; BioAnalytica Biotechnology Systems Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time Series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Immunogenomics Market Characteristics
3. Immunogenomics Market Trends And Strategies
4. Immunogenomics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Immunogenomics Growth Analysis And Strategic Analysis Framework
- 5.1. Global Immunogenomics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Immunogenomics Market Growth Rate Analysis
- 5.4. Global Immunogenomics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Immunogenomics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Immunogenomics Total Addressable Market (TAM)
6. Immunogenomics Market Segmentation
- 6.1. Global Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Instruments
- Consumables
- Software
- Services
- 6.2. Global Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Next-Generation Sequencing
- Microarray
- Polymerase Chain Reaction
- Other Technologies
- 6.3. Global Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oncology
- Infectious Diseases
- Autoimmune Disorders
- Transplantation
- Other Applications
- 6.4. Global Immunogenomics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals And Clinics
- Research Institutes
- Pharmaceutical And Biotechnology Companies
- Other End-Users
- 6.5. Global Immunogenomics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Sequencers
- Microarray scanners
- Flow cytometers
- 6.6. Global Immunogenomics Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Reagents
- Kits
- Assay panels
- 6.7. Global Immunogenomics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Data analysis software
- Bioinformatics tools
- Visualization platforms
- 6.8. Global Immunogenomics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Sequencing services
- Genomic profiling
- Bioinformatics support
7. Immunogenomics Market Regional And Country Analysis
- 7.1. Global Immunogenomics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Immunogenomics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Immunogenomics Market
- 8.1. Asia-Pacific Immunogenomics Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Immunogenomics Market
- 9.1. China Immunogenomics Market Overview
- 9.2. China Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Immunogenomics Market
- 10.1. India Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Immunogenomics Market
- 11.1. Japan Immunogenomics Market Overview
- 11.2. Japan Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Immunogenomics Market
- 12.1. Australia Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Immunogenomics Market
- 13.1. Indonesia Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Immunogenomics Market
- 14.1. South Korea Immunogenomics Market Overview
- 14.2. South Korea Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Immunogenomics Market
- 15.1. Western Europe Immunogenomics Market Overview
- 15.2. Western Europe Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Immunogenomics Market
- 16.1. UK Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Immunogenomics Market
- 17.1. Germany Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Immunogenomics Market
- 18.1. France Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Immunogenomics Market
- 19.1. Italy Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Immunogenomics Market
- 20.1. Spain Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Immunogenomics Market
- 21.1. Eastern Europe Immunogenomics Market Overview
- 21.2. Eastern Europe Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Immunogenomics Market
- 22.1. Russia Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Immunogenomics Market
- 23.1. North America Immunogenomics Market Overview
- 23.2. North America Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Immunogenomics Market
- 24.1. USA Immunogenomics Market Overview
- 24.2. USA Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Immunogenomics Market
- 25.1. Canada Immunogenomics Market Overview
- 25.2. Canada Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Immunogenomics Market
- 26.1. South America Immunogenomics Market Overview
- 26.2. South America Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Immunogenomics Market
- 27.1. Brazil Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Immunogenomics Market
- 28.1. Middle East Immunogenomics Market Overview
- 28.2. Middle East Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Immunogenomics Market
- 29.1. Africa Immunogenomics Market Overview
- 29.2. Africa Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Immunogenomics Market Competitive Landscape And Company Profiles
- 30.1. Immunogenomics Market Competitive Landscape
- 30.2. Immunogenomics Market Company Profiles
- 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. BGI Group Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. GenScript Biotech Corporation Overview, Products and Services, Strategy and Financial Analysis
31. Immunogenomics Market Other Major And Innovative Companies
- 31.1. CareDx Inc.
- 31.2. Oxford Nanopore Technologies plc
- 31.3. Genewiz LLC
- 31.4. Adaptive Biotechnologies Corporation
- 31.5. GenomOncology LLC
- 31.6. Personalis Inc.
- 31.7. Variantyx Inc.
- 31.8. CD Genomics Inc.
- 31.9. Sengenics Corporation
- 31.10. GeneCentric Therapeutics Inc.
- 31.11. Immunogenomics Inc.
- 31.12. ImmuQuad Biotechnologies Inc.
- 31.13. Neomics Pharmaceuticals LLC
- 31.14. Yemaachi Biotech Ltd.
- 31.15. BioAnalytica Biotechnology Systems Inc.
32. Global Immunogenomics Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Immunogenomics Market
34. Recent Developments In The Immunogenomics Market
35. Immunogenomics Market High Potential Countries, Segments and Strategies
- 35.1 Immunogenomics Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Immunogenomics Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Immunogenomics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
